The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study

July 18, 2022 updated by: Murk Niaz, Sindh Institute of Urology and Transplantation
This cross-sectional study, conducted at the Sindh Institute of Urology and Transplantation (SIUT), involved a retrospective data review of all the patients diagnosed with breast cancer from March 2017 to December 2021. The demographic characteristics, clinical presentation, stage of the disease, and histopathological characteristics were analyzed.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

690

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Sindh
      • Karachi, Sindh, Pakistan
        • Sindh Institute of Urology and Transplantation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All breast cancer patients registered at the Breast Clinic, at the Sindh Institute of Urology and Transplantation (SIUT), Karachi from March 2017 till December 2021 were included

Description

Inclusion Criteria:

  • All patients diagnosed with breast cancer

Exclusion Criteria:

  • The patients that were lost to follow-up after the first consultation and those consulting for a second opinion were excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Patients with breast cancer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographic characteristics of patients with breast cancer
Time Frame: At the time of presentation
age, gender, residence, marital status
At the time of presentation
Risk factors of patients with breast cancer
Time Frame: At the time of presentation
age at menarche, menopause, parity, breastfeeding, contraception, family history, body mass index
At the time of presentation
Clinical presentation of patients with breast cancer
Time Frame: At the time of presentation
site and duration
At the time of presentation
Stage of the breast cancer
Time Frame: At the time of presentation
American Joint Committee on Cancer (AJCC) Anatomic Stage Groups for breast cancer
At the time of presentation
Histopathological characteristics of patients with breast cancer
Time Frame: At the time of presentation
tumor type, hormone receptor status, Ki-67, and grade
At the time of presentation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sindh Institute of Urology and Transplantation

Investigators

  • Principal Investigator: Murk Niaz, Sindh Institute of Urology and Transplantation
  • Principal Investigator: Bushra Shirazi, Sindh Institute of Urology and Transplantation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2022

Primary Completion (Actual)

May 1, 2022

Study Completion (Actual)

May 1, 2022

Study Registration Dates

First Submitted

July 14, 2022

First Submitted That Met QC Criteria

July 14, 2022

First Posted (Actual)

July 18, 2022

Study Record Updates

Last Update Posted (Actual)

July 21, 2022

Last Update Submitted That Met QC Criteria

July 18, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Breast Audit

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe